首页 > 最新文献

Current radiopharmaceuticals最新文献

英文 中文
Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation- Induced Small Intestine Injury. 纳米姜黄素减轻辐射引起的小肠损伤的组织病理学评价。
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.2174/1874471015666220901142858
Alireza Ghanbar Z, Bagher Farhood, Farshid Alazmani Noodeh, Reza Mosaed, Gholamreza Hassanzadeh, Hamed Bagheri, Masoud Najafi

Aim: In the current study, we aimed to mitigate radiation-induced small intestinal toxicity using post-irradiation treatment with nano-micelle curcumin.

Background: Small intestine is one of the most radiosensitive organs within the body. Wholebody exposure to an acute dose of ionizing radiation may lead to severe injuries to this tissue and may even cause death after some weeks.

Objective: This study aimed to evaluate histopathological changes in the small intestine following whole-body irradiation and treatment with nanocurcumin.

Materials and methods: Forty male Nordic Medical Research Institute mice were grouped into control, treatment with 100 mg/kg nano-micelle curcumin, whole-body irradiation with cobalt-60 gamma-rays (dose rate of 60 cGy/min and a single dose of 7 Gy), and treatment with 100 mg/kg nano-micelle curcumin 1 day after whole-body irradiation for 4 weeks. Afterward, all mice were sacrificed for histopathological evaluation of their small intestinal tissues.

Results: Irradiation led to severe damage to villi, crypts, glands as well as vessels, leading to bleeding. Administration of nano-micelle curcumin after whole-body irradiation showed a statistically significant improvement in radiation toxicity of the duodenum, jejunum and ileum (including a reduction in infiltration of polymorphonuclear cells, villi length shortening, goblet cells injury, Lieberkühn glands injury and bleeding). Although treatment with nano-micelle curcumin showed increased bleeding in the ileum for non-irradiated mice, its administration after irradiation was able to reduce radiation-induced bleeding in the ileum.

Conclusion: Treatment with nano-micelle curcumin may be useful for mitigation of radiationinduced gastrointestinal system toxicity via suppression of inflammatory cells' infiltration and protection against villi and crypt shortening.

目的:在本研究中,我们旨在通过纳米胶束姜黄素辐照后处理减轻辐射引起的小肠毒性。背景:小肠是人体对放射性最敏感的器官之一。全身暴露于急性剂量的电离辐射可能导致该组织严重损伤,甚至可能在几周后导致死亡。目的:本研究旨在评价纳米姜黄素全身照射和治疗后小肠的组织病理学变化。材料与方法:选取北欧医学研究所雄性小鼠40只,随机分为对照组、100 mg/kg纳米胶束姜黄素治疗组、钴-60 γ射线全身照射组(剂量率60 cGy/min,单次剂量7 Gy)和100 mg/kg纳米胶束姜黄素治疗组,连续照射4周。之后,处死所有小鼠,对其小肠组织进行组织病理学评估。结果:辐照对大鼠绒毛、隐窝、腺体及血管造成严重损伤,导致出血。全身照射后给予纳米胶束姜黄素,显示十二指肠、空肠和回肠的辐射毒性有统计学意义的改善(包括减少多形核细胞浸润、绒毛长度缩短、杯状细胞损伤、lieberk腺损伤和出血)。虽然纳米胶束姜黄素治疗显示未辐照小鼠回肠出血增加,但辐照后给药能够减少辐射引起的回肠出血。结论:纳米胶束姜黄素治疗可能通过抑制炎症细胞浸润和保护绒毛和隐窝缩短来减轻辐射引起的胃肠道毒性。
{"title":"Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation- Induced Small Intestine Injury.","authors":"Alireza Ghanbar Z,&nbsp;Bagher Farhood,&nbsp;Farshid Alazmani Noodeh,&nbsp;Reza Mosaed,&nbsp;Gholamreza Hassanzadeh,&nbsp;Hamed Bagheri,&nbsp;Masoud Najafi","doi":"10.2174/1874471015666220901142858","DOIUrl":"https://doi.org/10.2174/1874471015666220901142858","url":null,"abstract":"<p><strong>Aim: </strong>In the current study, we aimed to mitigate radiation-induced small intestinal toxicity using post-irradiation treatment with nano-micelle curcumin.</p><p><strong>Background: </strong>Small intestine is one of the most radiosensitive organs within the body. Wholebody exposure to an acute dose of ionizing radiation may lead to severe injuries to this tissue and may even cause death after some weeks.</p><p><strong>Objective: </strong>This study aimed to evaluate histopathological changes in the small intestine following whole-body irradiation and treatment with nanocurcumin.</p><p><strong>Materials and methods: </strong>Forty male Nordic Medical Research Institute mice were grouped into control, treatment with 100 mg/kg nano-micelle curcumin, whole-body irradiation with cobalt-60 gamma-rays (dose rate of 60 cGy/min and a single dose of 7 Gy), and treatment with 100 mg/kg nano-micelle curcumin 1 day after whole-body irradiation for 4 weeks. Afterward, all mice were sacrificed for histopathological evaluation of their small intestinal tissues.</p><p><strong>Results: </strong>Irradiation led to severe damage to villi, crypts, glands as well as vessels, leading to bleeding. Administration of nano-micelle curcumin after whole-body irradiation showed a statistically significant improvement in radiation toxicity of the duodenum, jejunum and ileum (including a reduction in infiltration of polymorphonuclear cells, villi length shortening, goblet cells injury, Lieberkühn glands injury and bleeding). Although treatment with nano-micelle curcumin showed increased bleeding in the ileum for non-irradiated mice, its administration after irradiation was able to reduce radiation-induced bleeding in the ileum.</p><p><strong>Conclusion: </strong>Treatment with nano-micelle curcumin may be useful for mitigation of radiationinduced gastrointestinal system toxicity via suppression of inflammatory cells' infiltration and protection against villi and crypt shortening.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":"16 1","pages":"57-63"},"PeriodicalIF":2.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9431594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Current State of 44Ti/44Sc Radionuclide Generator Systems and Separation Chemistry. 44Ti/44Sc 放射性核素发生器系统和分离化学的现状。
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.2174/1874471016666221111154424
Christine E Schmidt, Leah Gajecki, Melissa A Deri, Vanessa A Sanders

In recent years, there has been an increased interest in 44Ti/44Sc generators as an onsite source of 44Sc for medical applications without needing a proximal cyclotron. The relatively short half-life (3.97 hours) and high positron branching ratio (94.3%) of 44Sc make it a viable candidate for positron emission tomography (PET) imaging. This review discusses current 44Ti/44Sc generator designs, focusing on their chemistry, drawbacks, post-elution processing, and relevant preclinical studies of the 44Sc for potential PET radiopharmaceuticals.

近年来,人们对 44Ti/44Sc 发生器的兴趣与日俱增,因为它是一种无需近端回旋加速器的现场 44Sc 医疗应用源。44Sc 相对较短的半衰期(3.97 小时)和较高的正电子支化率(94.3%)使其成为正电子发射断层扫描(PET)成像的可行候选物质。本综述讨论了目前的 44Ti/44Sc 发生器设计,重点是其化学性质、缺点、洗脱后处理以及 44Sc 用于潜在 PET 放射性药物的相关临床前研究。
{"title":"Current State of <sup>44</sup>Ti/<sup>44</sup>Sc Radionuclide Generator Systems and Separation Chemistry.","authors":"Christine E Schmidt, Leah Gajecki, Melissa A Deri, Vanessa A Sanders","doi":"10.2174/1874471016666221111154424","DOIUrl":"10.2174/1874471016666221111154424","url":null,"abstract":"<p><p>In recent years, there has been an increased interest in <sup>44</sup>Ti/<sup>44</sup>Sc generators as an onsite source of <sup>44</sup>Sc for medical applications without needing a proximal cyclotron. The relatively short half-life (3.97 hours) and high positron branching ratio (94.3%) of <sup>44</sup>Sc make it a viable candidate for positron emission tomography (PET) imaging. This review discusses current <sup>44</sup>Ti/<sup>44</sup>Sc generator designs, focusing on their chemistry, drawbacks, post-elution processing, and relevant preclinical studies of the <sup>44</sup>Sc for potential PET radiopharmaceuticals.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":"16 2","pages":"95-106"},"PeriodicalIF":2.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10266873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Meet the Editorial Board Member 会见编辑委员会成员
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-09-01 DOI: 10.2174/187447101503220622142219
K. Kairemo
{"title":"Meet the Editorial Board Member","authors":"K. Kairemo","doi":"10.2174/187447101503220622142219","DOIUrl":"https://doi.org/10.2174/187447101503220622142219","url":null,"abstract":"<jats:sec>\u0000<jats:title />\u0000<jats:p />\u0000</jats:sec>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48031706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fully Automated Methods for [18F]FDG and [18F]-NaF Productions Using Explora FDG4: Validation and Reliability of Multi-Subsequent Preparations for Clinical Applications. 使用Explora FDG4生产[18F]FDG和[18F]-NaF的全自动方法:临床应用多后续制剂的验证和可靠性。
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-05-18 DOI: 10.2174/1874471015666220518115244
E. Awad, H. Ali, James Lamb, E. Al‐Momani
BACKGROUND The worldwide usage of [18F]-sodium fluoride in clinical applications increase the interest of the facility of its production. The development of a new automated method for multi-preparations of [18F]-NaF and [18F]FDG on an Explora FDG4 module is described. Explora FDG4 is one of the most widely used synthesizers for FDG production in daily routine use and specifically designed to run up to four different productions with single module. Therefore, slight modifications were carried out in order to increase the potential of the synthesizer to perform more radiopharmaceuticals. METHODS A fully automated method for multi-preparations of [18F]-NaF and [18F]FDG using Explora FDG4 was performed. Slight modifications of the Explora's hardware and software configuration were applied. A new elution vial for NaF preparation was installed and connected to the free position to MVP1. Quality control was carried-out using the standard analytical methods that applied for GMP production. RESULTS This modification successfully provides preparation of [18F]-NaF without affecting the daily FDG production using one set preparation. [18F]-NaF was obtained in a high radiochemical yield (>90%, n=100) in 10 min total preparation time. The quality control results for both obtained products FDG (RCP >95%) and NaF (RCP >98%)showed that the radiopharmaceuticals were in compliance with USP and Ph.Eur. specifications and compatible with clinical applications. CONCLUSION A rapid and simple method for multi preparations of [18F]-NaF and [18F]FDG using single Explora module was designed. Yet, the chemistry module has the potential to generate more radiopharmaceuticals to decrease the cost of preparation of [18F]-NaF comparing with the cassette-based synthesizers, reducing radiation exposure resulted by manual preparations and increase the reproducibility of [18F]-NaF preparation.
[18F]-氟化钠在世界范围内的临床应用增加了对其生产设施的兴趣。本文介绍了在Explora FDG4模块上开发的一种新的自动化方法,用于多种制备[18F]-NaF和[18F]FDG。explorora FDG4是在日常使用中最广泛使用的FDG生产合成器之一,专门设计用于运行多达四个不同的生产与单个模块。因此,进行了轻微的修改,以增加合成器的潜力,以执行更多的放射性药物。方法采用Explora FDG4全自动制备[18F]-NaF和[18F]FDG。对探索者的硬件和软件配置进行了轻微的修改。安装了一个新的NaF制备洗脱瓶,并连接到MVP1的自由位置。质量控制采用GMP生产标准的分析方法进行。结果该修饰成功地制备了[18F]-NaF,而不影响每天的FDG产量。[18F]-NaF在10 min的总制备时间内获得了很高的放射化学产率(>90%,n=100)。所得产品FDG (RCP >95%)和NaF (RCP >98%)的质量控制结果表明,两种放射性药物均符合USP和Ph.Eur标准。规格和兼容临床应用。结论设计了一种快速简便的用单个explore模块制备[18F]-NaF和[18F]FDG的方法。然而,与盒式合成器相比,化学模块有潜力产生更多的放射性药物,以降低[18F]-NaF的制备成本,减少手工制备造成的辐射暴露,提高[18F]-NaF制备的可重复性。
{"title":"Fully Automated Methods for [18F]FDG and [18F]-NaF Productions Using Explora FDG4: Validation and Reliability of Multi-Subsequent Preparations for Clinical Applications.","authors":"E. Awad, H. Ali, James Lamb, E. Al‐Momani","doi":"10.2174/1874471015666220518115244","DOIUrl":"https://doi.org/10.2174/1874471015666220518115244","url":null,"abstract":"BACKGROUND The worldwide usage of [18F]-sodium fluoride in clinical applications increase the interest of the facility of its production. The development of a new automated method for multi-preparations of [18F]-NaF and [18F]FDG on an Explora FDG4 module is described. Explora FDG4 is one of the most widely used synthesizers for FDG production in daily routine use and specifically designed to run up to four different productions with single module. Therefore, slight modifications were carried out in order to increase the potential of the synthesizer to perform more radiopharmaceuticals. METHODS A fully automated method for multi-preparations of [18F]-NaF and [18F]FDG using Explora FDG4 was performed. Slight modifications of the Explora's hardware and software configuration were applied. A new elution vial for NaF preparation was installed and connected to the free position to MVP1. Quality control was carried-out using the standard analytical methods that applied for GMP production. RESULTS This modification successfully provides preparation of [18F]-NaF without affecting the daily FDG production using one set preparation. [18F]-NaF was obtained in a high radiochemical yield (>90%, n=100) in 10 min total preparation time. The quality control results for both obtained products FDG (RCP >95%) and NaF (RCP >98%)showed that the radiopharmaceuticals were in compliance with USP and Ph.Eur. specifications and compatible with clinical applications. CONCLUSION A rapid and simple method for multi preparations of [18F]-NaF and [18F]FDG using single Explora module was designed. Yet, the chemistry module has the potential to generate more radiopharmaceuticals to decrease the cost of preparation of [18F]-NaF comparing with the cassette-based synthesizers, reducing radiation exposure resulted by manual preparations and increase the reproducibility of [18F]-NaF preparation.","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2022-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46334444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of knowledge and level of radiation safety awareness among Radiographers working in Nuclear Medicine. 评估从事核医学工作的放射技师的辐射安全知识及意识水平。
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-04-25 DOI: 10.2174/1874471015666220425121713
Mpumelelo Nyathi
BACKGROUNDRadiopharmaceuticals are used for diagnosis, treatment, staging and follow up of various diseases. However, there is concern that the ionizing radiation (gamma rays, α and ß particles) may result in the exposure of radiographers with limited knowledge of the principles of radiation protection and safety, raising the risk of cancer induction.OBJECTIVETo investigate the knowledge and level of radiation safety awareness among radiographers at a tertiary hospital.METHODSIt is an analytical cross-sectional study. A validated two-part questionnaire was implemented to consenting radiographers in a Nuclear Medicine Department. Part 1 gathered demographic information (age, gender, work experience, attendance to/or passing ionizing radiation protection courses). Part 2 covered questions related to knowledge and level of awareness of radiation protection principles.RESULTSFive radiographers voluntary participated (2/5 were males while 3/5 were females). Three age groups were distinguishable, 21-30, 41-50 and 51-60 years. In the age group of 21-30 years, there was one male with just over 4 years of experience while in the age group 41-50, there were three females with less than three years of experience and in the age group 51-60, there was one male radiographer with over 20 years of experience. All the radiographers showed a high level of awareness and knowledge of radiation safety principles.CONCLUSIONEducation coupled with training in radiation protection is an essential tool for instilling radiation awareness among radiographers. However, education alone is not enough, further skills in preparation and administration of radiopharmaceuticals will reduce exposures.
背景放射性药物用于各种疾病的诊断、治疗、分期和随访。然而,有人担心电离辐射(伽马射线、α和ß粒子)可能会导致放射技师在辐射防护和安全原则知识有限的情况下暴露,从而增加癌症诱发的风险。目的了解某三级医院放射技师辐射安全知识及意识水平。方法这是一项分析性的横断面研究。一份经验证的由两部分组成的问卷被应用于核医学部门的同意放射技师。第1部分收集了人口统计信息(年龄、性别、工作经验、参加/或通过电离辐射防护课程)。第2部分涉及与辐射防护原则的知识和意识水平有关的问题。结果放射技师自愿参加(2/5为男性,3/5为女性)。三个年龄组是可区分的,21-30岁,41-50岁和51-60岁。在21-30岁的年龄组中,有一名男性有4年以上的工作经验,而在41-50岁的年龄段中,有三名女性的工作经验不足3年,在51-60岁的年龄段里,有一位男性放射技师的工作经验超过20年。所有放射技师对辐射安全原则的认识和知识都很高。结论辐射防护教育与培训是在放射技师中灌输辐射意识的重要工具。然而,光靠教育是不够的,进一步掌握放射性药物的制备和管理技能将减少暴露。
{"title":"Assessment of knowledge and level of radiation safety awareness among Radiographers working in Nuclear Medicine.","authors":"Mpumelelo Nyathi","doi":"10.2174/1874471015666220425121713","DOIUrl":"https://doi.org/10.2174/1874471015666220425121713","url":null,"abstract":"BACKGROUND\u0000Radiopharmaceuticals are used for diagnosis, treatment, staging and follow up of various diseases. However, there is concern that the ionizing radiation (gamma rays, α and ß particles) may result in the exposure of radiographers with limited knowledge of the principles of radiation protection and safety, raising the risk of cancer induction.\u0000\u0000\u0000OBJECTIVE\u0000To investigate the knowledge and level of radiation safety awareness among radiographers at a tertiary hospital.\u0000\u0000\u0000METHODS\u0000It is an analytical cross-sectional study. A validated two-part questionnaire was implemented to consenting radiographers in a Nuclear Medicine Department. Part 1 gathered demographic information (age, gender, work experience, attendance to/or passing ionizing radiation protection courses). Part 2 covered questions related to knowledge and level of awareness of radiation protection principles.\u0000\u0000\u0000RESULTS\u0000Five radiographers voluntary participated (2/5 were males while 3/5 were females). Three age groups were distinguishable, 21-30, 41-50 and 51-60 years. In the age group of 21-30 years, there was one male with just over 4 years of experience while in the age group 41-50, there were three females with less than three years of experience and in the age group 51-60, there was one male radiographer with over 20 years of experience. All the radiographers showed a high level of awareness and knowledge of radiation safety principles.\u0000\u0000\u0000CONCLUSION\u0000Education coupled with training in radiation protection is an essential tool for instilling radiation awareness among radiographers. However, education alone is not enough, further skills in preparation and administration of radiopharmaceuticals will reduce exposures.","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43700386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of radiation exposure dose for nuclear medicine workers from 18F-FDG, 99mTc MDP and 99mTc. 核医学工作人员18F-FDG、99mTc - MDP和99mTc辐射暴露剂量评估。
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-04-13 DOI: 10.2174/1874471015666220413114927
Abdulrahman M Al-Esaei, Emran Eisa Saleh, R. M. E. Shazly, S. Elmaghraby, M. Khalil, A. Kany
BACKGROUNDNuclear medicine or diagnostic radiology personnel are always exposed to low-level radiation from radionuclides used in medical diagnostics, which lead to potential biological hazards or effects.OBJECTIVEExternal exposure for workers in two nuclear medicine centers was measured by recruiting 120 patients.METHODSThree nuclear medicine examinations were performed using F18-FDG PET/CT, 99mTc-MDP bones scan, and 99mTc thyroid scan by a digital radiation dosimeter.RESULTSThe average received accumulative radiation dose for workers was found to be 0.838±0.17, 0.527±0.11 and 0.270±0.05 μSv for F18-FDG PET/CT, 99mTc-MDP bones scan, and 99mTc thyroid scan, respectively. The annual effective dose for workers was estimated to be 2.09±0.42, 1.34±0.27 and 0.68±0.14 mSv, respectively. Moreover, the average patient-to-staff dose coefficients were found to be 0.024±0.005, 0.003±0.001, and 0.007±0.002 μSv m2/MBq h for F18-FDG PET/CT, 99mTc-MDP bones scan, and 99mTc thyroid scan, respectively.CONCLUSIONIt is clear from the results that the radiation doses received by workers during the nuclear medicine imaging examinations were less than the doses recommended by the International Commission on Radiological Protection (ICRP) for such examinations.
背景核医学或放射诊断人员总是暴露在医疗诊断中使用的放射性核素的低水平辐射下,这会导致潜在的生物危害或影响。目的通过招募120名患者,测量两个核医学中心工作人员的外照射。方法应用F18-FDG PET/CT、99mTc-MDP骨显像和99mTc-甲状腺数字放射剂量仪进行三项核医学检查。结果F18-FDG PET/CT、99mTc-MDP骨骼扫描和99mTc-甲状腺扫描的工人平均累积辐射剂量分别为0.838±0.17、0.527±0.11和0.270±0.05μSv。工人的年有效剂量估计分别为2.09±0.42、1.34±0.27和0.68±0.14 mSv。此外,F18-FDG PET/CT、99mTc-MDP骨骼扫描和99mTc甲状腺扫描的患者与工作人员的平均剂量系数分别为0.024±0.005、0.003±0.001和0.007±0.002μSv m2/MBq h。结论从结果中可以清楚地看出,工作人员在核医学成像检查中接受的辐射剂量低于国际辐射防护委员会(ICRP)为此类检查建议的剂量。
{"title":"Assessment of radiation exposure dose for nuclear medicine workers from 18F-FDG, 99mTc MDP and 99mTc.","authors":"Abdulrahman M Al-Esaei, Emran Eisa Saleh, R. M. E. Shazly, S. Elmaghraby, M. Khalil, A. Kany","doi":"10.2174/1874471015666220413114927","DOIUrl":"https://doi.org/10.2174/1874471015666220413114927","url":null,"abstract":"BACKGROUND\u0000Nuclear medicine or diagnostic radiology personnel are always exposed to low-level radiation from radionuclides used in medical diagnostics, which lead to potential biological hazards or effects.\u0000\u0000\u0000OBJECTIVE\u0000External exposure for workers in two nuclear medicine centers was measured by recruiting 120 patients.\u0000\u0000\u0000METHODS\u0000Three nuclear medicine examinations were performed using F18-FDG PET/CT, 99mTc-MDP bones scan, and 99mTc thyroid scan by a digital radiation dosimeter.\u0000\u0000\u0000RESULTS\u0000The average received accumulative radiation dose for workers was found to be 0.838±0.17, 0.527±0.11 and 0.270±0.05 μSv for F18-FDG PET/CT, 99mTc-MDP bones scan, and 99mTc thyroid scan, respectively. The annual effective dose for workers was estimated to be 2.09±0.42, 1.34±0.27 and 0.68±0.14 mSv, respectively. Moreover, the average patient-to-staff dose coefficients were found to be 0.024±0.005, 0.003±0.001, and 0.007±0.002 μSv m2/MBq h for F18-FDG PET/CT, 99mTc-MDP bones scan, and 99mTc thyroid scan, respectively.\u0000\u0000\u0000CONCLUSION\u0000It is clear from the results that the radiation doses received by workers during the nuclear medicine imaging examinations were less than the doses recommended by the International Commission on Radiological Protection (ICRP) for such examinations.","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2022-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41994637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Methodological aspects and prognostic value of metabolic tumor volume assessed with 18F-FDG PET/CT in lymphomas. 18F-FDG PET/CT评估淋巴瘤代谢肿瘤体积的方法学方面和预后价值。
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-03-29 DOI: 10.2174/1874471015666220329120631
F. Tutino, E. Giovannini, S. Pastorino, O. Ferrando, G. Giovacchini, A. Ciarmiello
Metabolic tumor volume (MTV) assessed by pretreatment 18F-FDG PET/CT has shown significant prognostic value across many lymphoma types, although not yet used in clinical practice for technical concerns and need for standardization. Numerous studies on the prognostic value of MTV in lymphomas have been published in recent years, but there is still no full agreement on the best methodology for MTV calculation. In this paper, we reviewed the methodological aspects of MTV assessment and reported recent works about its impact on outcome in lymphomas, with a focus on Hodgkin lymphoma (HL) and diffuse large B cell lymphoma (DLBCL).
通过预处理18F-FDG PET/CT评估的代谢肿瘤体积(MTV)在许多淋巴瘤类型中显示出显著的预后价值,尽管由于技术问题和标准化需求,尚未在临床实践中使用。近年来,关于MTV在淋巴瘤中的预后价值的许多研究已经发表,但对于MTV计算的最佳方法仍然没有完全一致。在本文中,我们回顾了MTV评估的方法学方面,并报道了其对淋巴瘤预后影响的最新工作,重点是霍奇金淋巴瘤(HL)和弥漫性大B细胞淋巴瘤(DLBCL)。
{"title":"Methodological aspects and prognostic value of metabolic tumor volume assessed with 18F-FDG PET/CT in lymphomas.","authors":"F. Tutino, E. Giovannini, S. Pastorino, O. Ferrando, G. Giovacchini, A. Ciarmiello","doi":"10.2174/1874471015666220329120631","DOIUrl":"https://doi.org/10.2174/1874471015666220329120631","url":null,"abstract":"Metabolic tumor volume (MTV) assessed by pretreatment 18F-FDG PET/CT has shown significant prognostic value across many lymphoma types, although not yet used in clinical practice for technical concerns and need for standardization. Numerous studies on the prognostic value of MTV in lymphomas have been published in recent years, but there is still no full agreement on the best methodology for MTV calculation. In this paper, we reviewed the methodological aspects of MTV assessment and reported recent works about its impact on outcome in lymphomas, with a focus on Hodgkin lymphoma (HL) and diffuse large B cell lymphoma (DLBCL).","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2022-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45677044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imperatorin attenuates proliferation of MCF-7 Cells in combination with Radiotherapy or Hyperthermia. Imperatorin与放射治疗或热疗相结合可减弱MCF-7细胞的增殖。
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-03-18 DOI: 10.2174/1874471015666220318122202
P. Amini, Saeedeh Jafari Nodooshan, M. Ashrafizadeh, A. Aliasgharzadeh, Z. Vakili, S. Tavakoli, T. Aryafar, A. Musa, M. Najafi, S. Taeb, Bagher Farhood
AIMThe aim of this study was to evaluate possible sensitization effect of imperatorin (IMP) for radiotherapy and hyperthermia (HT).BACKGROUNDBreast cancer is one of the most common types of malignancies in the world. Cancer resistance is an unavoidable consequence of therapy with radiation or other modalities. Numerous researches aimed at improving cancer response to therapy are ongoing.OBJECTIVEThus, in this study, we investigated the potential sensitizing effect of IMP in combination with external radiotherapy (ERT) or HT.METHODAfter treatment of MCF-7 breast cancer cells with IMP, cells were exposed to 4 Gy X-rays or HT (42 °C for 1 hour). The viability of MCF-7 cells was measured using MTT assay. Furthermore, the expression of pro-apoptotic genes including Bax, Bcl-2, Caspase-3, Caspase-8 and Caspase-9 were investigated using real-time PCR. The sensitizing effect of IMP in combination with ERT or HT was calculated and compared to ERT or HT alone.RESULTSResults showed an increase in the expression of pro-apoptotic genes and downregulation of anti-apoptotic Bcl-2 following ERT and HT. Furthermore, cell viability reduced following these treatments. IMP was able to augment these effects of ERT and HT.CONCLUSIONIMP could increase the efficiency of HT and ERT. This effect of IMP may suggest it as an adjuvant for increasing the therapeutic efficiency of ERT.
目的评价欧前胡素(IMP)对放疗和热疗(HT)可能的致敏作用。背景:乳腺癌是世界上最常见的恶性肿瘤之一。癌症耐药性是放疗或其他治疗方式不可避免的结果。许多旨在改善癌症治疗反应的研究正在进行中。因此,本研究探讨了IMP联合外部放疗(ERT)或HT的潜在致敏效应。方法用IMP处理MCF-7乳腺癌细胞后,将细胞暴露于4 Gy x射线或高温(42°C)下1小时。MTT法测定MCF-7细胞活力。采用实时荧光定量PCR检测促凋亡基因Bax、Bcl-2、Caspase-3、Caspase-8、Caspase-9的表达。计算IMP联合ERT或HT的致敏效果,并与单独ERT或HT进行比较。结果ERT和HT后,促凋亡基因Bcl-2表达升高,抗凋亡基因Bcl-2表达下调。此外,这些处理后细胞活力降低。IMP能够增强ERT和HT的这些作用。结论imp能提高HT和ERT的治疗效率。IMP的这种作用可能表明它是一种提高ERT治疗效率的辅助剂。
{"title":"Imperatorin attenuates proliferation of MCF-7 Cells in combination with Radiotherapy or Hyperthermia.","authors":"P. Amini, Saeedeh Jafari Nodooshan, M. Ashrafizadeh, A. Aliasgharzadeh, Z. Vakili, S. Tavakoli, T. Aryafar, A. Musa, M. Najafi, S. Taeb, Bagher Farhood","doi":"10.2174/1874471015666220318122202","DOIUrl":"https://doi.org/10.2174/1874471015666220318122202","url":null,"abstract":"AIM\u0000The aim of this study was to evaluate possible sensitization effect of imperatorin (IMP) for radiotherapy and hyperthermia (HT).\u0000\u0000\u0000BACKGROUND\u0000Breast cancer is one of the most common types of malignancies in the world. Cancer resistance is an unavoidable consequence of therapy with radiation or other modalities. Numerous researches aimed at improving cancer response to therapy are ongoing.\u0000\u0000\u0000OBJECTIVE\u0000Thus, in this study, we investigated the potential sensitizing effect of IMP in combination with external radiotherapy (ERT) or HT.\u0000\u0000\u0000METHOD\u0000After treatment of MCF-7 breast cancer cells with IMP, cells were exposed to 4 Gy X-rays or HT (42 °C for 1 hour). The viability of MCF-7 cells was measured using MTT assay. Furthermore, the expression of pro-apoptotic genes including Bax, Bcl-2, Caspase-3, Caspase-8 and Caspase-9 were investigated using real-time PCR. The sensitizing effect of IMP in combination with ERT or HT was calculated and compared to ERT or HT alone.\u0000\u0000\u0000RESULTS\u0000Results showed an increase in the expression of pro-apoptotic genes and downregulation of anti-apoptotic Bcl-2 following ERT and HT. Furthermore, cell viability reduced following these treatments. IMP was able to augment these effects of ERT and HT.\u0000\u0000\u0000CONCLUSION\u0000IMP could increase the efficiency of HT and ERT. This effect of IMP may suggest it as an adjuvant for increasing the therapeutic efficiency of ERT.","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":"1 1","pages":""},"PeriodicalIF":2.3,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41987454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Does Heparin Affect 99mTc-MAA In Vitro Stability? 肝素是否影响99mTc-MAA的体外稳定性?
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-01-01 DOI: 10.2174/1874471015666220204142608
Teresa Scotognella, Valerio Lanni, Fabiana Moresi, Alessio Rizzo, Andrea Guarneri, Venanzio Valenza

Introduction: Pulmonary embolism (PE) can be diagnosed by perfusion lung scintigraphy using human albumin macroaggregates labelled 99mTc (99mTc-MAA). When PE is suspected, subcutaneous Low Molecular Weight Heparin (LMWH) should be administered even before the results of the PE diagnostic flowchart. In our study, we aimed to evaluate a possible interaction (in vitro interference) between 99mTc-MAA and LMWH.

Methods: The reconstitution of MAA kit was performed according to the manufacturer's instruction. After labelling, we carried out the following preparations: a standard dose of 99mTc-MAA alone, as control; 99mTc-MAA and enoxaparin at different ratios. According to the manufacturer's instruction, the radiochemical purity was performed and evaluated immediately (T0), after 15 and 30 minutes after incubation (T15 and T30).

Results: We compared the radiochemical purity of 99mTc-MAA with: (i) radiochemical purity of 99mTc-MAA and enoxaparin (11 ratio), (ii) radiochemical purity of 99mTc-MAA and enoxaparin (0.5 ratio), and (iii) radiochemical purity of 99mTc-MAA and enoxaparin (ratio 2). No significant differences were found between all the measured parameters at each time point for each ratio. We also tested the stability of 99mTc-MAA in physiological conditions (at 37°C in PBS): the initial radiochemical purity of 99mTc-MAA was 99.78%. The values of 99mTc-MAA radiochemical purity were high in all conditions of possible interaction with LMWH, with values ranging from 98.00% at T0 to 95% at T30.

Conclusion: We found no statistically significant change in the in vitro stability of 99mTc-MAA in the presence of enoxaparin, excluding a possible direct interference. Future studies will be needed to check the 99mTc-MAA stability under physiological conditions.

肺栓塞(PE)可以通过使用人白蛋白大聚集体标记99mTc (99mTc- maa)进行肺灌注显像诊断。当怀疑PE时,应在PE诊断流程图结果出来之前就皮下注射低分子量肝素(LMWH)。在我们的研究中,我们旨在评估99mTc-MAA与低分子肝素之间可能的相互作用(体外干扰)。方法:按照生产厂家说明书对MAA试剂盒进行重组。标记后,我们进行了以下准备:标准剂量99mTc-MAA单独作为对照;99mTc-MAA与依诺肝素的不同比例。根据制造商的说明,在孵育15分钟和30分钟后(T15和T30)立即进行放射化学纯度检测和评估(T0)。结果:我们将99mTc-MAA的放射化学纯度与:(i) 99mTc-MAA与依诺肝素的放射化学纯度(11比),(ii) 99mTc-MAA与依诺肝素的放射化学纯度(0.5比),(iii) 99mTc-MAA与依诺肝素的放射化学纯度(2比)进行了比较。在每个比值的每个时间点,所有测量参数之间均无显著差异。我们还测试了99mTc-MAA在生理条件下(37℃PBS)的稳定性:99mTc-MAA的初始放射化学纯度为99.78%。99mTc-MAA放射化学纯度在所有可能与低分子肝素相互作用的条件下都很高,T0时为98.00%,T30时为95%。结论:我们发现在依诺肝素存在的情况下,99mTc-MAA的体外稳定性无统计学意义的变化,排除了可能的直接干扰。99mTc-MAA在生理条件下的稳定性有待进一步研究。
{"title":"Does Heparin Affect <sup>99m</sup>Tc-MAA In Vitro Stability?","authors":"Teresa Scotognella,&nbsp;Valerio Lanni,&nbsp;Fabiana Moresi,&nbsp;Alessio Rizzo,&nbsp;Andrea Guarneri,&nbsp;Venanzio Valenza","doi":"10.2174/1874471015666220204142608","DOIUrl":"https://doi.org/10.2174/1874471015666220204142608","url":null,"abstract":"<p><strong>Introduction: </strong>Pulmonary embolism (PE) can be diagnosed by perfusion lung scintigraphy using human albumin macroaggregates labelled <sup>99m</sup>Tc (<sup>99m</sup>Tc-MAA). When PE is suspected, subcutaneous Low Molecular Weight Heparin (LMWH) should be administered even before the results of the PE diagnostic flowchart. In our study, we aimed to evaluate a possible interaction (in vitro interference) between <sup>99m</sup>Tc-MAA and LMWH.</p><p><strong>Methods: </strong>The reconstitution of MAA kit was performed according to the manufacturer's instruction. After labelling, we carried out the following preparations: a standard dose of <sup>99m</sup>Tc-MAA alone, as control; <sup>99m</sup>Tc-MAA and enoxaparin at different ratios. According to the manufacturer's instruction, the radiochemical purity was performed and evaluated immediately (T<sub>0</sub>), after 15 and 30 minutes after incubation (T<sub>15</sub> and T<sub>30</sub>).</p><p><strong>Results: </strong>We compared the radiochemical purity of <sup>99m</sup>Tc-MAA with: (i) radiochemical purity of <sup>99m</sup>Tc-MAA and enoxaparin (11 ratio), (ii) radiochemical purity of <sup>99m</sup>Tc-MAA and enoxaparin (0.5 ratio), and (iii) radiochemical purity of <sup>99m</sup>Tc-MAA and enoxaparin (ratio 2). No significant differences were found between all the measured parameters at each time point for each ratio. We also tested the stability of <sup>99m</sup>Tc-MAA in physiological conditions (at 37°C in PBS): the initial radiochemical purity of <sup>99m</sup>Tc-MAA was 99.78%. The values of 99mTc-MAA radiochemical purity were high in all conditions of possible interaction with LMWH, with values ranging from 98.00% at T0 to 95% at T<sub>30</sub>.</p><p><strong>Conclusion: </strong>We found no statistically significant change in the in vitro stability of <sup>99m</sup>Tc-MAA in the presence of enoxaparin, excluding a possible direct interference. Future studies will be needed to check the <sup>99m</sup>Tc-MAA stability under physiological conditions.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":"15 3","pages":"199-204"},"PeriodicalIF":2.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39596097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification. 高灵敏度BGO PET/CT扫描仪的临床应用:采集方案和重建参数对病灶量化的影响。
IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-01-01 DOI: 10.2174/1874471015666220107100200
Elena De Ponti, Cinzia Crivellaro, Sabrina Morzenti, Lavinia Monaco, Sergio Todde, Claudio Landoni, Federica Elisei, Monica Musarra, Luca Guerra

Aims: The aim of this retrospective study was to investigate SUVs variability with respect to lesion size, administered dose, and reconstruction algorithm.

Background: SUVmax and SUVpeak are influenced by technical factors as count statistics and reconstruction algorithms.

Objective: To fulfill the aim, we evaluated the SUVs variability with respect to lesion size, administered dose, and reconstruction algorithm (ordered - subset expectation maximization plus point spread function option - OSEM+PSF, regularized Bayesian Penalized Likelihood - BPL) in a 5 - rings BGO PET/CT scanner.

Methods: Discovery IQ scanner (GE Healthcare, Milwaukee, Wisconsin, US) was used for list mode acquisition of 25 FDG patients, 12 injected with 3.7 MBq/kg (Standard Dose protocol - SD) and 13 injected with 1.8 MBq/kg (Low Dose protocol - LD). Each acquisition was reconstructed at different time/FOV with both OSEM+PSF algorithm and BPL using seven different beta factors. SUVs were calculated in 70 lesions and analysed in function of time/FOV and Beta. Image quality was evaluated as a coefficient of variation of the liver (CV - liver).

Results: SUVs were not considerably affected by time/FOV. However, SUVs were influenced by beta: differences were higher in small lesions (37% for SUVmax, 15% for SUVpeak) compared to larger ones (14% and 6%). CV - liver ranged from 6% with Beta-500 (LD and SD) to 13% with Beta- 200 (LD). CV - liver of BPL with Beta-350 (optimized for clinical practice in our institution) in LD was lower than CV - liver of OSEM+PSF in SD.

Conclusion: When a high sensitivity 5 - rings BGO PET/CT scanner is used with the same reconstruction algorithm, quantification by means of SUVmax and SUVpeak is a robust standard compared to the activity and scan duration. However, both SUVs and image quality are influenced by reconstruction algorithms and the related parameters should be considered to obtain the best compromise between detectability, quantification, and noise.

目的:本回顾性研究的目的是研究suv在病变大小、给药剂量和重建算法方面的可变性。背景:SUVmax和SUVpeak受计数统计和重构算法等技术因素的影响。目的:为了实现目的,我们在5环BGO PET/CT扫描仪上评估了SUVs在病变大小、给药剂量和重建算法(有序子集期望最大化+点扩散函数选项- OSEM+PSF,正则化贝叶斯惩罚似似性- BPL)方面的变异性。方法:采用Discovery IQ扫描仪(GE Healthcare, Milwaukee, Wisconsin, US)对25例FDG患者进行清单模式采集,其中12例注射3.7 MBq/kg(标准剂量方案- SD), 13例注射1.8 MBq/kg(低剂量方案- LD)。采用OSEM+PSF算法和BPL方法,利用7种不同的beta因子,在不同的时间/视场对每个采集进行重构。计算70个病变的suv,并分析时间/FOV和Beta的函数。图像质量用肝脏变异系数(CV - liver)来评价。结果:suv受时间/视场的影响不明显。然而,suv受到β的影响:与较大的病变(14%和6%)相比,小病变(SUVmax为37%,SUVpeak为15%)的差异更高。CV -肝脏从β -500 (LD和SD)的6%到β - 200 (LD)的13%不等。BPL + β -350(针对我院临床实践优化)在LD中的CV -肝脏低于SD中OSEM+PSF的CV -肝脏。结论:采用相同重建算法的高灵敏度5环BGO PET/CT扫描仪,相对于活度和扫描时间,SUVmax和SUVpeak是一个可靠的定量标准。然而,suv和图像质量都受到重建算法的影响,需要考虑相关参数,以在可检测性、量化和噪声之间获得最佳折衷。
{"title":"Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification.","authors":"Elena De Ponti,&nbsp;Cinzia Crivellaro,&nbsp;Sabrina Morzenti,&nbsp;Lavinia Monaco,&nbsp;Sergio Todde,&nbsp;Claudio Landoni,&nbsp;Federica Elisei,&nbsp;Monica Musarra,&nbsp;Luca Guerra","doi":"10.2174/1874471015666220107100200","DOIUrl":"https://doi.org/10.2174/1874471015666220107100200","url":null,"abstract":"<p><strong>Aims: </strong>The aim of this retrospective study was to investigate SUVs variability with respect to lesion size, administered dose, and reconstruction algorithm.</p><p><strong>Background: </strong>SUV<sub>max</sub> and SUV<sub>peak</sub> are influenced by technical factors as count statistics and reconstruction algorithms.</p><p><strong>Objective: </strong>To fulfill the aim, we evaluated the SUVs variability with respect to lesion size, administered dose, and reconstruction algorithm (ordered - subset expectation <sub>max</sub>imization plus point spread function option - OSEM+PSF, regularized Bayesian Penalized Likelihood - BPL) in a 5 - rings BGO PET/CT scanner.</p><p><strong>Methods: </strong>Discovery IQ scanner (GE Healthcare, Milwaukee, Wisconsin, US) was used for list mode acquisition of 25 FDG patients, 12 injected with 3.7 MBq/kg (Standard Dose protocol - SD) and 13 injected with 1.8 MBq/kg (Low Dose protocol - LD). Each acquisition was reconstructed at different time/FOV with both OSEM+PSF algorithm and BPL using seven different beta factors. SUVs were calculated in 70 lesions and analysed in function of time/FOV and Beta. Image quality was evaluated as a coefficient of variation of the liver (CV - liver).</p><p><strong>Results: </strong>SUVs were not considerably affected by time/FOV. However, SUVs were influenced by beta: differences were higher in small lesions (37% for SUV<sub>max</sub>, 15% for SUV<sub>peak</sub>) compared to larger ones (14% and 6%). CV - liver ranged from 6% with Beta-500 (LD and SD) to 13% with Beta- 200 (LD). CV - liver of BPL with Beta-350 (optimized for clinical practice in our institution) in LD was lower than CV - liver of OSEM+PSF in SD.</p><p><strong>Conclusion: </strong>When a high sensitivity 5 - rings BGO PET/CT scanner is used with the same reconstruction algorithm, quantification by means of SUV<sub>max</sub> and SUV<sub>peak</sub> is a robust standard compared to the activity and scan duration. However, both SUVs and image quality are influenced by reconstruction algorithms and the related parameters should be considered to obtain the best compromise between detectability, quantification, and noise.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":"15 3","pages":"218-227"},"PeriodicalIF":2.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39882451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Current radiopharmaceuticals
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1